Deseret Mutual Benefit Administrators’s Bristol-Myers Squibb BMY Stock Holding History

Deseret Mutual Benefit Administrators's BMY Position: Q1 2026 in Review

Deseret Mutual Benefit Administrators reduced its Bristol-Myers Squibb (BMY) stake by 23% in Q1 2026, selling an estimated $240K and leaving 13,968 shares worth $847K. The position accounts for 0.29% of the portfolio, ranked #69.

Deseret Mutual Benefit Administrators first reported a position in BMY in Q2 2021 and has held it in 20 quarters since. The position peaked at $1.94M in Q2 2022. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

• Deseret Mutual Benefit Administrators held 13,968 shares of Bristol-Myers Squibb worth $847K as of Q1 2026.
• Deseret Mutual Benefit Administrators sold 4,113 Bristol-Myers Squibb shares in Q1 2026, an estimated $240K.
• Bristol-Myers Squibb made up 0.29% of Deseret Mutual Benefit Administrators's portfolio in Q1 2026, its #69 holding.
• Deseret Mutual Benefit Administrators first reported a position in Bristol-Myers Squibb in Q2 2021 and has held it in 20 quarters since.
• Deseret Mutual Benefit Administrators's Bristol-Myers Squibb position peaked at $1.94M in Q2 2022.
• 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Deseret Mutual Benefit Administrators's 13F filing for Q1 2026, filed 8 May 2026.